GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Can B Corp (OTCPK:CANB) » Definitions » Gross Profit

Can B (CANB) Gross Profit : $-0.34 Mil (TTM As of Sep. 2024)


View and export this data going back to 2011. Start your Free Trial

What is Can B Gross Profit?

Can B's gross profit for the three months ended in Sep. 2024 was $-0.40 Mil. Can B's gross profit for the trailing twelve months (TTM) ended in Sep. 2024 was $-0.34 Mil.

Gross Margin % is calculated as gross profit divided by its revenue. Can B's gross profit for the three months ended in Sep. 2024 was $-0.40 Mil. Can B's Revenue for the three months ended in Sep. 2024 was $0.02 Mil. Therefore, Can B's Gross Margin % for the quarter that ended in Sep. 2024 was -2,673.33%.

Can B had a gross margin of -2,673.33% for the quarter that ended in Sep. 2024 => No sustainable competitive advantage

During the past 13 years, the highest Gross Margin % of Can B was 152.38%. The lowest was -33.30%. And the median was 64.20%.

Warning Sign:

Can B Corp gross margin has been in long-term decline. The average rate of decline per year is -16.9%.


Can B Gross Profit Historical Data

The historical data trend for Can B's Gross Profit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Can B Gross Profit Chart

Can B Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Gross Profit
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.71 1.43 2.99 2.61 0.36

Can B Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Gross Profit Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.82 1.27 -0.82 -0.39 -0.40

Competitive Comparison of Can B's Gross Profit

For the Drug Manufacturers - Specialty & Generic subindustry, Can B's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Can B's Gross Profit Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Can B's Gross Profit distribution charts can be found below:

* The bar in red indicates where Can B's Gross Profit falls into.


;
;

Can B Gross Profit Calculation

Gross Profit is the different between the sale prices and the cost of buying or producing the goods.

Can B's Gross Profit for the fiscal year that ended in Dec. 2023 is calculated as

Gross Profit (A: Dec. 2023 )=Revenue - Cost of Goods Sold
=2.156 - 1.797
=0.36

Can B's Gross Profit for the quarter that ended in Sep. 2024 is calculated as

Gross Profit (Q: Sep. 2024 )=Revenue - Cost of Goods Sold
=0.015 - 0.416
=-0.40

Gross Profit for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.34 Mil.

Gross Profit is the numerator in the calculation of Gross Margin.

Can B's Gross Margin % for the quarter that ended in Sep. 2024 is calculated as

Gross Margin % (Q: Sep. 2024 )=Gross Profit (Q: Sep. 2024 ) / Revenue (Q: Sep. 2024 )
=(Revenue - Cost of Goods Sold) / Revenue
=-0.40 / 0.015
=-2,673.33 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Can B  (OTCPK:CANB) Gross Profit Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Can B had a gross margin of -2,673.33% for the quarter that ended in Sep. 2024 => No sustainable competitive advantage


Can B Gross Profit Related Terms

Thank you for viewing the detailed overview of Can B's Gross Profit provided by GuruFocus.com. Please click on the following links to see related term pages.


Can B Business Description

Traded in Other Exchanges
N/A
Address
960 South Broadway, Suite 120, Hicksville, NY, USA, 11801
Can B Corp is engaged in the business of promoting health and wellness through its development, manufacture and sale of products containing cannabinoids derived from hemp biomass and the licensing of durable medical devices. The company focuses on developing a line of proprietary products in the Hemp Industry.
Executives
Mckenzie Webster Ltd 10 percent owner DMS HOUSE, DR. ROYCE DRIVE, GEORGE TOWN, GRAND CAYMAN E9 KY1-1102
Stanley L Teeple director, officer: CFO, Director, and Secretary 94 ARTHUR HILL COURT, HENDERSON NV 89014
Andrew Holtmeyer officer: EVP Business Development 65 LAUREN AVE, SUITE 301, HUNTINGTON STATION NY 11746
Heggenhougen Rolv director 90 NORTH CHURCH STREET, GEORGETOWN E9 KY1-1102
David J Posel officer: COO 6103 CARMEL LN SE, LACEY WA 98503
Rolv Heggenhougen 10 percent owner 445 NE 12TH AVENUE, FORT LAUDERDALE FL 33301
Marco Alfonsi director, 10 percent owner, officer: CEO, Board Member 44 EAST END AVENUE, HICKSVILLE NY 11801
Carl Dilley director 15500 ROOSEVELT BLVD., SUITE 301, CLEARWATER FL 33760

Can B Headlines

From GuruFocus

Four Cannabis Companies Capitalizing On Increased CBD Demand

By Marketwired Marketwired 08-18-2021